Manifestations of Perihepatic Lymph Nodes in Acute Flare of Chronic Hepatitis B: Association with HBeAg Status and with HBeAg Seroconversion

It has been observed that enlargement of perihepatic lymph nodes may be seen in patients with chronic hepatitis B, particularly during acute flares of CHB. We hypothesized that there may be a correlation between the nodal change patterns in CHB patients with acute flare and HBeAg status. Perihepatic lymph node sizes of 87 patients with acute flares of CHB were documented, with a median follow up of 43 months. Patients were separated into 3 groups, HBeAg-positive with HBe seroconversion (group 1), HBeAg-positive without HBe seroconversion (group 2), and HBeAg-negative (group 3). Group 1 has the highest incidence of enlarged lymph nodes (92.3%) compared with group 2 (75.8%) and group 3 (46.8%) (p = 0.003). And if nodal width at acute flare was > 8mm and interval change of nodal width was >3mm, the incidence of HBeAg seroconversion will be 75% (p<0.001). Conclusion Larger perihepatic lymph nodes are seen in CHB acute flare patients with positive HBeAg and the magnitude of nodal width change may predict HBeAg seroconversion at recovery.

[1]  J. Shu,et al.  Chronic hepatitis B: Enlarged perihepatic lymph nodes correlated with hepatic histopathology. , 2013, World journal of radiology.

[2]  Z. Tian,et al.  Characterization of the liver-draining lymph nodes in mice and their role in mounting regional immunity to HBV , 2013, Cellular and Molecular Immunology.

[3]  Ding‐Shinn Chen,et al.  Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation. , 2012, The Journal of infectious diseases.

[4]  G. McCaughan,et al.  Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation. , 2012, Journal of hepatology.

[5]  Zhi‐hua Liu,et al.  High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B. , 2012, Journal of hepatology.

[6]  EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. , 2012, Journal of hepatology.

[7]  H. Kuo,et al.  The early on-treatment perihepatic lymph node response predicts sustained viral response of anti-hepatitis C virus therapy , 2011, European journal of gastroenterology & hepatology.

[8]  Antonio Bertoletti,et al.  A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. , 2010, Journal of hepatology.

[9]  H. Hsu,et al.  Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion. , 2010, Gastroenterology.

[10]  W. Shin,et al.  Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B. , 2009, Gastroenterology.

[11]  D. Vassilopoulos,et al.  Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B , 2008, Journal of viral hepatitis.

[12]  G. Fattovich,et al.  Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years , 2007, Gut.

[13]  C. Chu,et al.  Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion , 2007, Journal of viral hepatitis.

[14]  H. Kuo,et al.  Enlarged lymph nodes in porta hepatis: Sonographic sign of chronic hepatitis B and C infections , 2006, Journal of clinical ultrasound : JCU.

[15]  E. Telemo,et al.  Induction of antigen‐specific regulatory T cells in the liver‐draining celiac lymph node following oral antigen administration , 2005, Immunology.

[16]  M. Yuen,et al.  Longitudinal Study of Hepatitis Activity and Viral Replication before and after HBeAg Seroconversion in Chronic Hepatitis B Patients Infected with Genotypes B and C , 2004, Journal of Clinical Microbiology.

[17]  C. Chu,et al.  Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. , 2004, The American journal of medicine.

[18]  Ding‐Shinn Chen,et al.  Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers , 2004, Journal of medical virology.

[19]  E. Jouve,et al.  Lymph node enlargement within the hepatoduodenal ligament in patients with chronic hepatitis C reflects the immunological cellular response of the host. , 2003, Journal of hepatology.

[20]  Chien-Jen Chen,et al.  Hepatitis B e antigen and the risk of hepatocellular carcinoma. , 2002, The New England journal of medicine.

[21]  H. Chiou,et al.  Long‐term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B , 2002, Hepatology.

[22]  M. Choi,et al.  Clinical Significance of Enlarged Perihepatic Lymph Nodes in Chronic Hepatitis B , 2001, Journal of clinical gastroenterology.

[23]  M. Soresi,et al.  Evaluation by ultrasound of abdominal lymphadenopathy in chronic hepatitis C , 1999, American Journal of Gastroenterology.

[24]  Ding‐Shinn Chen,et al.  Hepatitis B Virus Infection , 2007 .

[25]  M. Levrero,et al.  Ultrasound detection of abdominal lymphadenomegaly in subjects with hepatitis C virus infection and persistently normal transaminases: a predictive index of liver histology severity. , 1998, Journal of hepatology.

[26]  Y. Okada,et al.  Lymph nodes in the hepatoduodenal ligament: US appearances with CT and MR correlation. , 1996, Clinical radiology.

[27]  J. Sung,et al.  Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. , 1992, The Journal of clinical investigation.

[28]  Chien-Jen Chen,et al.  Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma , 1991, Hepatology.

[29]  M. Zoli,et al.  Prevalence and Significance of Abdominal Lymphadenopathy in Patients with Chronic Liver Disease: An Ultrasound Study , 1990, Journal of clinical gastroenterology.

[30]  A. Lok,et al.  Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. , 1990, Journal of hepatology.

[31]  T. Ezaki,et al.  The liver lymphatics as a migratory pathway of macrophages from the sinusoids to the celiac lymph nodes in the rat. , 1990, Archives of histology and cytology.

[32]  J. Rodés,et al.  Analysis of factors predicting early seroconversion to anti-HBe in HBeAg-positive chronic hepatitis B. , 1988, Journal of hepatology.

[33]  A. Lok,et al.  Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. , 1987, Gastroenterology.

[34]  J. Hoofnagle,et al.  Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis , 1987, Hepatology.

[35]  C. Chu,et al.  Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. , 1987, Gastroenterology.

[36]  J. Hoofnagle,et al.  Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis. , 1985, Gastroenterology.

[37]  H. Thomas,et al.  Natural history of chronic hepatitis B virus infection in taiwan: Studies of hepatitis B virus DNA in serum , 1985, Hepatology.

[38]  C. Chu,et al.  Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. , 1983, Gastroenterology.

[39]  J. Hoofnagle,et al.  Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. , 1981, Annals of internal medicine.

[40]  M. Rugge,et al.  Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. , 1980, Gastroenterology.

[41]  S. Sherlock,et al.  Cellular immunity and hepatitis-associated, Australia antigen liver disease. , 1972, Lancet.